Company / Revenue per Share
Chemed Corp. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$166.45
FY2025
5-year range
$129.44 / $166.45
FY2021-FY2025
Trend
+3.4%
vs FY2024
Sector context
#16 of 147
Health Care
What the data says
Chemed Corp.'s revenue per share of $166.45 is higher than 89% of companies in the Health Care sector (FY2025). Revenue per Share has increased for 9 consecutive years, from $88.39 in FY2016 to $166.45 in FY2025.
Based on SEC 10-K filings.
166.45 in FY2025 with a 5-year CAGR of +6.1%. Top quartile in the Health Care sector.
Improved from $142.08 to $166.45 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +6.1%
- 10-Year CAGR
- -
Sector benchmark
+30.2% above sector average
Key checks
Key Insights
- Chemed Corp.'s revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 3.4% year-over-year.
- Ranks #16 out of 147 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $166.45 | +3.4% |
| FY2024 | $161.02 | +13.3% |
| FY2023 | $142.08 | +9.1% |
| FY2022 | $130.20 | +0.6% |
| FY2021 | $129.44 | +4.6% |
| FY2020 | $123.76 | +6.9% |
| FY2019 | $115.79 | +9.1% |
| FY2018 | $106.18 | +11.0% |
| FY2017 | $95.67 | +8.2% |
| FY2016 | $88.39 | +6.4% |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026